BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32332706)

  • 21. [Expression and action of hepatic sterol regulatory element-binding protein-1c in patients with nonalcoholic fatty liver disease].
    Yang ZX; Sun H; Shen W
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):823-6. PubMed ID: 19032865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models.
    Zhang Y; Meng T; Zuo L; Bei Y; Zhang Q; Su Z; Huang Y; Pang J; Xiang Q; Yang H
    Mar Drugs; 2017 Jun; 15(6):. PubMed ID: 28587208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
    Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of hepatic liver X receptor α- and sterol regulatory element binding protein-1c-mediated lipid disorder in the pathogenesis of non-alcoholic steatohepatitis in rats.
    Ai ZL; Zhu CH; Min M; Wang J; Lan CH; Fan LL; Sun WJ; Chen DF
    J Int Med Res; 2011; 39(4):1219-29. PubMed ID: 21986124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1.
    Gosis BS; Wada S; Thorsheim C; Li K; Jung S; Rhoades JH; Yang Y; Brandimarto J; Li L; Uehara K; Jang C; Lanza M; Sanford NB; Bornstein MR; Jeong S; Titchenell PM; Biddinger SB; Arany Z
    Science; 2022 Apr; 376(6590):eabf8271. PubMed ID: 35420934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice.
    Xu JL; Li LY; Wang YQ; Li YQ; Shan M; Sun SZ; Yu Y; Wang B
    J Lipid Res; 2018 Jan; 59(1):35-47. PubMed ID: 29113994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease.
    Teng W; Zhao L; Yang S; Zhang C; Liu M; Luo J; Jin J; Zhang M; Bao C; Li D; Xiong W; Li Y; Ren F
    J Control Release; 2019 Aug; 307():139-149. PubMed ID: 31233775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
    World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pivotal Role of TNF-α in the Development and Progression of Nonalcoholic Fatty Liver Disease in a Murine Model.
    Kakino S; Ohki T; Nakayama H; Yuan X; Otabe S; Hashinaga T; Wada N; Kurita Y; Tanaka K; Hara K; Soejima E; Tajiri Y; Yamada K
    Horm Metab Res; 2018 Jan; 50(1):80-87. PubMed ID: 28922680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.
    Yamada K; Mizukoshi E; Sunagozaka H; Arai K; Yamashita T; Takeshita Y; Misu H; Takamura T; Kitamura S; Zen Y; Nakanuma Y; Honda M; Kaneko S
    Liver Int; 2015 Feb; 35(2):582-90. PubMed ID: 25219574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells.
    Chen A; Chen X; Cheng S; Shu L; Yan M; Yao L; Wang B; Huang S; Zhou L; Yang Z; Liu G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):538-548. PubMed ID: 29486327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
    Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ
    Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of Chinese herbal medicine Jiangzhi Granule on expressions of liver X receptor α and sterol regulatory element-binding protein-1c in a rat model of non-alcoholic fatty liver disease].
    Yang LL; Wang M; Liu T; Song HY; Li DF; Zheng PY; Liu P; Ji G; Ji G
    Zhong Xi Yi Jie He Xue Bao; 2011 Sep; 9(9):998-1004. PubMed ID: 21906525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCBP6 upregulates human SREBP1c expression by binding to C/EBPβ-binding site in the SREBP1c promoter.
    Yang X; Han M; Liu S; Yuan X; Liu X; Feng S; Zhou L; Li Y; Lu H; Cheng J; Lin S
    BMB Rep; 2018 Jan; 51(1):33-38. PubMed ID: 29187281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
    Han HY; Lee SK; Choi BK; Lee DR; Lee HJ; Kim TW
    Biol Pharm Bull; 2019; 42(2):255-260. PubMed ID: 30713255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes.
    Zhang Y; Lei T; Huang JF; Wang SB; Zhou LL; Yang ZQ; Chen XD
    Mol Cell Endocrinol; 2011 Aug; 342(1-2):41-7. PubMed ID: 21664250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver.
    Sim WC; Park S; Lee KY; Je YT; Yin HQ; Choi YJ; Sung SH; Park SJ; Park HJ; Shin KJ; Lee BH
    Biochem Pharmacol; 2014 Aug; 90(4):414-24. PubMed ID: 24955981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
    Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
    Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
    Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.